Your browser doesn't support javascript.
loading
Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure.
Duseja, Ajay; De, Arka; Taneja, Sunil; Choudhury, Ashok Kumar; Devarbhavi, Harshad; Hu, Jinhua; Hamid, Saeed S; Butt, Amna Subhan; Jafri, Syed Muhammad Wasim; Ghazinian, Hasmik; Chawla, Yogesh K; Dhiman, Radha K; Duan, Zhongping; Chen, Yu; Tan, Soek Siam; Lee, Guan Huei; Lim, Seng Gee; Kim, Dong Joon; Sahu, Manoj; Sollano, Jose D; Carpio, Gian; Mohan Prasad, Virukalpatti Gopalratnam; Abbas, Zaigham; Lesmana, Laurentius A; Lesmana, Cosmas Rinaldi; Eapen, Chundamannil E; Goel, Ashish; Sood, Ajit; Midha, Vandana; Goyal, Omesh; Dokmeci, Abdul Kadir; Ning, Qin; Chen, Tao; Ma, Ke; Payawal, Diana A; Lau, George K K; Al Mahtab, Mamun; Rahman, Salimur; Alam, Mohd Shahinul; Shukla, Akash; Shrestha, Ananta; Shah, Samir; Kalal, Chetan Ramesh; Kumar, Guresh; Jain, Priyanka; Paulson, Irene; Sarin, Shiv Kumar.
Afiliação
  • Duseja A; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • De A; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Taneja S; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Choudhury AK; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Devarbhavi H; Department of Gastroenterology, St John's Medical College Hospital, Bangalore, India.
  • Hu J; Liver Failure Treatment and Research Center, 302 Military Hospital of China, Beijing, China.
  • Hamid SS; The Aga Khan University, Karachi, Pakistan.
  • Butt AS; The Aga Khan University, Karachi, Pakistan.
  • Jafri SMW; The Aga Khan University, Karachi, Pakistan.
  • Ghazinian H; Department of Hepatology, Nork Clinical Hospital of Infectious Diseases, Yerevan, Armenia.
  • Chawla YK; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Dhiman RK; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Duan Z; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Chen Y; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Tan SS; Department of Hepatology, Selayang Hospital, Selangor, Malaysia.
  • Lee GH; Division of Gastroenterology and Hepatology, National University Health System, Singapore.
  • Lim SG; Medicine, Yong Loo Lin School of Medicine, Singapore.
  • Kim DJ; Hallym University Medical Center, Seoul, Korea.
  • Sahu M; ISM and SUM Hospital, Bhubaneswar, India.
  • Sollano JD; Medicine, Santo Tomas, Manila, Philippines.
  • Carpio G; University of Santo Tomas, Manila, Philippines.
  • Mohan Prasad VG; VGM Hospital, Coimbatore, India.
  • Abbas Z; Department of Hepatogastroenterology, Ziauddin University, Karachi, Pakistan.
  • Lesmana LA; Medicine, Medistra Hospital, South Jakarta, Indonesia.
  • Lesmana CR; Medicine, Medistra Hospital, South Jakarta, Indonesia.
  • Eapen CE; Christian Medical College, Vellore, India.
  • Goel A; Christian Medical College, Vellore, India.
  • Sood A; Dayanand Medical College and Hospital, Ludhiana, India.
  • Midha V; Dayanand Medical College and Hospital, Ludhiana, India.
  • Goyal O; Dayanand Medical College and Hospital, Ludhiana, India.
  • Dokmeci AK; Department of Gastroenterology, Ankara University, Ankara, Turkey.
  • Ning Q; Tongji Medical College, Wuhan, China.
  • Chen T; Tongji Medical College, Wuhan, China.
  • Ma K; Tongji Medical College, Wuhan, China.
  • Payawal DA; Cardinal Santos Medical Center, San Juan, Philippines.
  • Lau GKK; Humanity and Health Medical Centre, Hong Kong.
  • Al Mahtab M; Seth GS Medical College & Kem Hospital, Mumbai, India.
  • Rahman S; Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Alam MS; Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Shukla A; Seth GS Medical College & Kem Hospital, Mumbai, India.
  • Shrestha A; Foundation Nepal Sitapaila Height, Kathmandu, Nepal.
  • Shah S; Hepatology, Global Hospital, Mumbai, India.
  • Kalal CR; Hepatology, Global Hospital, Mumbai, India.
  • Kumar G; Clinical Research, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Jain P; Clinical Research, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Paulson I; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Sarin SK; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Liver Int ; 41(1): 150-157, 2021 01.
Article em En | MEDLINE | ID: mdl-32970356
ABSTRACT

BACKGROUND:

Metabolic risk factors may impact the severity and outcome of alcoholic liver disease. The present study evaluated this effect in patients with alcohol-associated acute-on-chronic liver failure (ACLF).

METHODOLOGY:

One thousand two hundred and sixteen prospectively enrolled patients with ACLF (males 98%, mean age 42.5 ± 9.4 years, mean CTP, MELD and AARC scores of 12 ± 1.4, 29.7 ± 7 and 9.8 ± 2 respectively) from the Asian Pacific Association for the Study of the Liver (APASL) ACLF Research Consortium (AARC) database were analysed retrospectively. Patients with or without metabolic risk factors were compared for severity (CTP, MELD, AARC scores) and day 30 and 90 mortality. Information on overweight/obesity, type 2 diabetes mellitus (T2DM), hypertension and dyslipidaemia were available in 1028 (85%), 1019 (84%), 1017 (84%) and 965 (79%) patients respectively.

RESULTS:

Overall, 392 (32%) patients died at day 30 and 528 (43%) at day 90. Overweight/obesity, T2DM, hypertension and dyslipidaemia were present in 154 (15%), 142 (14%), 66 (7%) and 141 (15%) patients, respectively, with no risk factors in 809 (67%) patients. Patients with overweight/obesity had higher MELD scores (30.6 ± 7.1 vs 29.2 ± 6.9, P = .007) and those with dyslipidaemia had higher AARC scores (10.4 ± 1.2 vs 9.8 ± 2, P = .014). Overweight/obesity was associated with increased day 30 mortality (HR 1.54, 95% CI 1.06-2.24, P = .023). None of other metabolic risk factors, alone or in combination, had any impact on disease severity or mortality. On multivariate analysis, overweight or obesity was significantly associated with 30-day mortality (aHR 1.91, 95% CI 1.41-2.59, P < .001), independent of age, CTP, MELD and AARC scores.

CONCLUSION:

Overweight/obesity and dyslipidaemia increase the severity of alcohol-associated ACLF, and the former also increases the short-term mortality in these patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Hepática Crônica Agudizada Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Hepática Crônica Agudizada Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia